Yahoo
NYSE American - Nasdaq Real Time Price USD

AIM ImmunoTech Inc. (AIM)

0.1607 +0.0062 (+4.01%)
At close: 4:00:00 PM EST
0.1600 -0.0007 (-0.44%)
After hours: 5:57:34 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
94
88
170
202
141
Cost of Revenue
122
128
31
42
0
Gross Profit
-28
-40
139
160
141
Operating Expense
10,243
11,624
19,911
32,076
20,064
Operating Income
-10,271
-11,664
-19,772
-31,916
-19,923
Net Non Operating Interest Income Expense
2,188
2,371
4,607
1,069
629
Other Income Expense
-5,193
-4,665
-2,155
1,885
-151
Pretax Income
-13,276
-13,958
-17,320
-28,962
-19,445
Net Income Common Stockholders
-13,276
-13,958
-17,320
-28,962
-19,445
Diluted NI Available to Com Stockholders
-13,276
-13,958
-17,320
-28,962
-19,445
Basic EPS
-0.71
-8.62
-30.92
-59.94
-39.96
Diluted EPS
-0.71
-8.62
-30.92
-59.94
-39.96
Basic Average Shares
6,662.1680
1,618.6170
560.1680
486.3390
480.9530
Diluted Average Shares
6,662.1680
1,618.6170
560.1680
486.3390
480.9530
Total Operating Income as Reported
-10,271
-11,664
-19,772
-31,916
-19,923
Total Expenses
10,365
11,752
19,942
32,118
20,064
Net Income from Continuing & Discontinued Operation
-13,276
-13,958
-17,320
-28,962
-19,445
Normalized Income
-12,525
-13,703
-16,769
-29,180
-17,804
Interest Income
3,180
3,183
5,192
1,069
629
Interest Expense
992
812
585
0
0
Net Interest Income
2,188
2,371
4,607
1,069
629
EBIT
-12,284
-13,146
-16,735
-28,962
-19,923
EBITDA
-12,089
-12,936
-16,489
-28,724
-19,667
Reconciled Cost of Revenue
122
128
31
42
0
Reconciled Depreciation
195
210
246
238
256
Net Income from Continuing Operation Net Minority Interest
-13,276
-13,958
-17,320
-28,962
-19,445
Total Unusual Items Excluding Goodwill
-751
-255
-551
218
-1,641
Total Unusual Items
-751
-255
-551
218
-1,641
Normalized EBITDA
-11,338
-12,681
-15,938
-28,942
-18,026
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 7/12/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: